Drug interactions with rifampicin: well known but not considered?

被引:1
|
作者
Strobach, Dorothea [1 ]
机构
[1] Univ Hosp Munich, Hosp Pharm, D-81377 Munich, Germany
关键词
D O I
10.1136/ejhpharm-2013-000314
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives Enquiries to the drug information centre revealed that clinicians were not aware of the importance of rifampicin drug interactions. We conducted a short time study to demonstrate the relevance of these interactions in the clinical setting today. Methods Over a total period of 4 weeks (two 2-week periods) we identified patients on rifampicin, performed a drug interaction test for their complete medication regime and analysed the results for severity of drug interactions. Results A total of 137 potential drug interactions were found in 26 patients, including 6 contraindications. For additional 80 combinations, treatment adjustment was required or probably necessary. Most interactions had not been considered for the patient, including all contraindications and drug interactions with anti-infectives. Conclusions Rifampicin drug interactions are of high relevance in the clinical setting today. However, clinicians failed to consider this issue for all patients. An individual drug interaction test is recommended for all patients given rifampicin. This is especially important when electronic patient records with integrated drug interaction tests are not available.
引用
收藏
页码:368 / 370
页数:3
相关论文
共 50 条
  • [1] PHARMACOKINETIC DRUG-INTERACTIONS WITH RIFAMPICIN
    VENKATESAN, K
    CLINICAL PHARMACOKINETICS, 1992, 22 (01) : 47 - 65
  • [2] Pharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir
    Wind, Sven
    Giessmann, Thomas
    Jungnik, Arvid
    Brand, Tobias
    Marzin, Kristell
    Bertulis, Julia
    Hocke, Julia
    Gansser, Dietmar
    Stopfer, Peter
    CLINICAL DRUG INVESTIGATION, 2014, 34 (03) : 173 - 182
  • [3] Pharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir
    Sven Wind
    Thomas Giessmann
    Arvid Jungnik
    Tobias Brand
    Kristell Marzin
    Julia Bertulis
    Julia Hocke
    Dietmar Gansser
    Peter Stopfer
    Clinical Drug Investigation, 2014, 34 : 173 - 182
  • [4] RHABDOMYOLYSIS: A LESS KNOWN SIDE EFFECT OF A WELL KNOWN DRUG
    Shahid, N.
    Bawany, M. Z.
    Sodeman, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (04) : 746 - 747
  • [5] Antidepressants: Clinically Relevant Drug Interactions to Be Considered
    Schellander, Rene
    Donnerer, Josef
    PHARMACOLOGY, 2010, 86 (04) : 203 - 215
  • [7] NEW MYOTOXIC DRUG INTERACTIONS BETWEEN STATINS AND RIFAMPICIN
    Han, X.
    Quinney, S.
    Skaar, T.
    Elmendord, J.
    Flockhart, D.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S44 - S44
  • [8] Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol
    Swaisland, HC
    Ranson, M
    Smith, RP
    Leadbetter, J
    Laight, A
    McKillop, D
    Wild, MJ
    CLINICAL PHARMACOKINETICS, 2005, 44 (10) : 1067 - 1081
  • [9] Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol
    Helen C. Swaisland
    Malcolm Ranson
    Robert P. Smith
    Joanna Leadbetter
    Alison Laight
    David McKillop
    Martin J. Wild
    Clinical Pharmacokinetics, 2005, 44 : 1067 - 1081
  • [10] The peculiarities of the process for manufacturing of wire from well known silver solders are considered
    Karpachev, V.M.
    Metallurgicheskaya i Gornorudnaya Promyshlennost, 2004, (02): : 83 - 84